WAVRE, Belgium — 13 September 2022: iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, today announces that clinical data on MINIject®, iSTAR Medical’s next-generation minimally invasive glaucoma surgical (MIGS) device for patients with glaucoma, will be presented by world-leading ophthalmology specialists at this year’s European Society of Cataract and Refractive Surgeons (ESCRS) Congress taking place in Milan, Italy from 16-20 September 2022.
Prof Kaweh Mansouri (Swiss Visio, Clinique de Montshoisi, Switzerland and iSTAR Medical’s newly appointed Chief Medical Officer), Dr Karsten Klabe (Breyer, Kaymak & Klabe Eye Surgery, Germany) and Prof. Dr. Burkhard Dick (University Eye Hospital Bochum, Germany) will be sharing clinical data for MINIject® across three presentations at the ESCRS Congress as follows:
Session: Instructional Course – Minimally invasive glaucoma surgery: time to shine
Date: 17 September 2022
Time: 16:00-17:30 CEST
Room: Amber 3
Presenter: Dr Kaweh Mansouri
Session: Minimally invasive glaucoma surgery
Date: 18 September 2022
Time: 14:00-15:30 CEST
Room: Red 1-2 – podium 4
Presenter: Dr Karsten Klabe
Session: Minimally invasive glaucoma surgery
Date: 18 September 2022
Time: 14:00-15:30 CEST
Room: Red 1-2 – podium 4
Presenter: Prof Dr Burkhard Dick
iSTAR Medical will also be exhibiting onsite throughout the Congress at booth C03. To arrange a meeting with one of our team members, please contact us at [email protected]
The ESCRS Congress seeks to promote education and research in the field of implant and refractive surgery and promotes the study and practice of ophthalmology. The annual event gathers glaucoma care providers including glaucoma specialists and surgeons, general ophthalmologists, optometrists, researchers, nurses, technicians, leaders of glaucoma patient organizations, for more information, click here.
EN
